Short Interest in GlucoTrack, Inc. (NASDAQ:GCTK) Increases By 223.2%

GlucoTrack, Inc. (NASDAQ:GCTK) was the target of a significant increase in short interest in April. As of April 30th, there was short interest totaling 2,166,796 shares, an increase of 223.2% from the April 15th total of 670,479 shares. Approximately 114.0% of the company’s stock are sold short. Based on an average trading volume of 9,640,460 shares, the short-interest ratio is presently 0.2 days.

Institutional Trading of GlucoTrack

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Ikarian Capital LLC acquired a new stake in GlucoTrack in the fourth quarter valued at $177,000. Boothbay Fund Management LLC purchased a new position in shares of GlucoTrack during the fourth quarter worth about $52,000. Finally, Bank of America Corp DE grew its holdings in shares of GlucoTrack by 102,125.0% during the second quarter. Bank of America Corp DE now owns 4,089 shares of the company’s stock worth $25,000 after purchasing an additional 4,085 shares during the last quarter. 10.92% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of GlucoTrack in a research note on Tuesday, April 21st. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.

GlucoTrack Stock Down 3.0%

GlucoTrack stock traded down $0.02 during midday trading on Friday, reaching $0.65. The company’s stock had a trading volume of 383,596 shares, compared to its average volume of 10,967,022. GlucoTrack has a fifty-two week low of $0.58 and a fifty-two week high of $15.90. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 0.08. The company has a market cap of $1.26 million, a P/E ratio of -0.04 and a beta of 0.78. The business has a 50-day simple moving average of $0.91 and a 200-day simple moving average of $2.97.

GlucoTrack Company Profile

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc and changed its name to GlucoTrack, Inc in November 2021. GlucoTrack, Inc was founded in 2001 and is based in Rutherford, New Jersey.